Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06450470

Use of a Freeze-dried Amniotic Membrane Post Crosslinking in Subjects With Progressive Keratoconus

Multicenter, Randomized Study Evaluating the Use of a Non-sutured Sterile Freeze-dried Amniotic Membrane Post Crosslinking in Subjects With Progressive Keratoconus

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
116 (estimated)
Sponsor
TBF Genie Tissulaire · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Crosslinking is a therapeutic technique used to increase the rigidity of the cornea in order to slow or stop progression of keratoconus. The main complication of the treatment of keratoconus by crosslinking is postoperative pain due to the removal of the corneal epithelium. Currently, the management of pain is done through the administration of artificial tears and paracetamol. The amniotic membrane is a biological tissue used in ophthalmology to treat injuries of the surface of the eye. It has healing and analgesic properties. The objective of this multicenter randomized study is to evaluate the benefit of placing an amniotic membrane on the eye post-crosslinking to reduce pain and promote corneal healing.

Conditions

Interventions

TypeNameDescription
DEVICETherapeutic lens aloneTherapeutic lens will be apposed on the patient's eye after crosslinking. Therapeutic lens will be maintained without interruption until the first postoperative visit (Day 2) when it will be removed by the investigator.
COMBINATION_PRODUCTTherapeutic lens + amniotic membrane (Visio-AMTRIX)Amniotic membrane (Visio-AMTRIX) will be apposed under therapeutic lens on the patient's eye after crosslinking. Amniotic membrane and therapeutic lens will be maintained without interruption until the first postoperative visit (Day 2) when it will be removed by the investigator.

Timeline

Start date
2024-11-25
Primary completion
2025-11-01
Completion
2025-11-01
First posted
2024-06-10
Last updated
2025-04-11

Locations

9 sites across 1 country: France

Source: ClinicalTrials.gov record NCT06450470. Inclusion in this directory is not an endorsement.